Global Tumor Microenvironment Market Size is valued at USD 1.7 Billion in 2024 and is predicted to reach USD 5.6 Billion by the year 2034 at a 13.2% CAGR during the forecast period for 2025-2034. The complex and dynamic environment around a tumour, which includes a range of cells, blood vessels, immune cells, signalling chemicals, and the extracellular matrix, is known as the tumour microenvironment (TME). This microenvironment is essential for ...
Report ID: 2268 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 179
Global Incontinence Care Products (ICP) Market Size is valued at USD 12.69 billion in 2024 and is predicted to reach USD 21.98 billion by the year 2034 at a 5.8% CAGR during the forecast period for 2025-2034. These incontinence care products are worn discreetly within undergarments and are made to absorb urine. Pull-up underwear and sanitary pads are made with the same hydrophobic layer used in disposable diapers. New and improved incontin...
Report ID: 2147 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Antibiotic Resistance Market Size is valued at 8.93 Billion in 2024 and is predicted to reach 16.99 Billion by the year 2034 at a 6.8% CAGR during the forecast period for 2025-2034. Antibiotics are antimicrobial chemicals that are used to treat bacterial infections. Strokes, sinus infections, urinary tract infections, ear infections, pneumonia, skin infections, and other diseases are all treated with them. The market has been supported b...
Report ID: 1244 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 185
Global Blood-Based Biomarker Market Size is valued at USD 7.9 Bn in 2024 and is predicted to reach USD 15.9 Bn by the year 2034 at a 7.4% CAGR during the forecast period for 2025-2034. A blood-based biomarker refers to a measurable and quantifiable characteristic in the blood that indicates a particular physiological or pathological process, or a response to a therapeutic intervention. Biomarkers are valuable tools in medicine and research as th...
Report ID: 2244 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Manual Patch Clamp Market Size is predicted to grow at a 4.5% CAGR during the forecast period for 2025-2034. Manual patch clamp is a versatile, high-resolution, low-throughput approach for measuring the currents generated by a single cell in response to stimulation. With the addition of innovative tactics and an increasing client preference, this market has been growing faster. Patch-clamp is a popular approach for researching ion c...
Report ID: 2196 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Non-Invasive Respiratory Therapy Market Size is valued at USD 2.45 Bn in 2024 and is predicted to reach USD 4.04 Bn by the year 2034 at a 5.2% CAGR during the forecast period for 2025-2034. Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. These treatments often treat respiratory diseases, including asthma...
Report ID: 2198 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Care Communications Market Size is valued at USD 3.3 Bn in 2024 and is predicted to reach USD 10.6 Bn by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Care communication pertains to the exchange of information and interactions among healthcare professionals, patients, and their families, intending to ensure the delivery of safe, effective, and patient-centred healthcare. The swift expansion of telehealth and tele...
Report ID: 2224 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Heparinoid Market Size is valued at USD 1.2 Billion in 2024 and is predicted to reach USD 1.7 Billion by the year 2034 at a 3.6% CAGR during the forecast period for 2025-2034. Heparinoid is an anti-thrombotic medication that decreases swelling in the veins just under the skin and helps to prevent the formation of tiny blood clots. To alleviate bruising, heparinoid is prescribed. Superficial thrombophlebitis causes internal bruising (haema...
Report ID: 2293 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Myasthenia Gravis Treatment Market Size is valued at USD 1.60 Bn in 2024 and is predicted to reach USD 3.34 Bn by the year 2034 at a 7.8% CAGR during the forecast period for 2025-2034. Myasthenia gravis is an uncommon neuromuscular illness characterized by gradual weakness of the muscles of the face, neck, upper and lower body, and respiratory system. Producing antibodies against the acetylcholine receptor disrupts the regular flow ...
Report ID: 2148 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 179
Global Integrase Inhibitors Market Size is valued at USD 15.8 Bn in 2024 and is predicted to reach USD 27.9 Bn by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034. Integrase inhibitors are a type of antiretroviral medications that work by inhibiting the viral enzyme integrase, which is responsible for mixing the viral genome into the DNA of the host cell. This is the mechanism of action of integrase inhibitors. Retr...
Report ID: 2089 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Pharmaceuticals